Pyrazine in prevention and treatment of strokes
US4859674A · kind A · utility
2Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 1988 |
| Grant date | Aug 22, 1989 |
| Priority date | — |
| Expiry date | Aug 3, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/495
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Neurologic dysfunction resulting from stroke is diminished by administering to a patient an effective amount of a tetra-substituted pyrazine over a relatively continuous regimen. Conveniently, an initial bolus is administered to bring the level of the drug up to a pre-determined blood level, followed by continuous infusion employing a pump or by continuous intravenous infusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.